Drugs / Novalin
last change Sep 2018 re-read 2 minutes ago

Novalin

Developed for
type 2 diabetes mellitus
Investigated by
Maya Guglin

Trials 1 · a red edge is where a trial was stopped

2017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
NCT02694289 Nov 2016 → Sep 2018 type 2 diabetes mellitus Maya Guglin Withdrawn No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Novalin “eg. Humulin, Lantus, NovalinNCT02694289